Header Logo

Connection

Robert Mannel to Pyrazines

Back to Details
This is a "connection" page, showing publications Robert Mannel has written about Pyrazines.
Robert Mannel
Connection Strength
0.083
Pyrazines
  1. A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2009 Nov; 115(2):215-20.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.